Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products; Public Hearing; Request for Comments; Correction Documents
Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products; Public Hearing; Request for Comments; Correction
 

Table of Contents Back to Top

FOR FURTHER INFORMATION CONTACT: Back to Top

Lori Jo Churchyard, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993, 240-402-7911.

SUPPLEMENTARY INFORMATION: Back to Top

In FR Doc. 2015-27703, appearing on pages 66845 and 66847 in the Federal Register of Friday, October 30, 2015, the following corrections are made:

1. On page 66845, in the third column under DATES, the third sentence is revised to read: “Persons seeking to attend (including FDA employees) or to present at the public hearing must register by January 8, 2016.”

2. On page 66847, in the first column under section IV. Attendance and Registration, the third sentence is revised to read: “Individuals who wish to attend (including FDA employees) or present at the public hearing must register by sending an email to [email protected] on or before January 8, 2016, and provide complete contact information, including name, title, affiliation, address, email, and phone number.”

Dated: December 21, 2015.

Leslie Kux,

Associate Commissioner for Policy.

[FR Doc. 2015-32686 Filed 12-28-15; 8:45 am]

BILLING CODE 4164-01-P